Disclosures for "Prevalence and Clinical Significance of Anti-MOG in the Cerebrospinal Fluid of Patients with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Systematic Review with Meta-Analysis"
-
Mr. Luna has nothing to disclose.
-
Mr. Velazco has nothing to disclose.
-
Mr. Acurio has nothing to disclose.
-
Mr. Vascones Roman has nothing to disclose.
-
Dr. Mantilla has nothing to disclose.
-
Mr. Alegre has nothing to disclose.
-
Mr. Vicuña has nothing to disclose.